SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Artiva Biotherapeutics Expects Workforce Reduction to Finish in Q1 2027

A SEC filing says Artiva expects the workforce reduction to be completed in Q1 2027, with most costs in Q4 2026.

ARTV

Related stories